Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| USANA HEALTH SCIENCES INCUSNA · Entity 6114 | 10% owner | September 03, 2025 | September 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
USANA HEALTH SCIENCES INC
Report date September 03, 2025 · Filed September 05, 2025
Jointly reported with WENTZ MYRON W
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectShares owned of record by Gull Global Limited | 7,408,345 |
Reported balance
After 2025-09-03 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-09-03 · Gift · Disposed 145,000 · Balance 7,408,345 F1: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. |
Filing footnotes · ownership attribution and instrument terms
F1: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2018 Filed Sep 7, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 8,896 | $125.39 | $1,115,469.44 |
DisclosureSEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,026,785 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $124.85 to $125.80, inclusive. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,026 | $129.97 | $263,319.22 |
DisclosureSEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,035,681 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $129.60 to $130.35, inclusive. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 6,179 | $129.15 | $798,017.85 |
DisclosureSEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,037,707 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $128.60 to $129.55, inclusive. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,945 | $128.11 | $633,503.95 |
DisclosureSEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,043,886 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $127.60 to $128.55, inclusive. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 6,783 | $127.06 | $861,847.98 |
DisclosureSEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,048,831 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $126.60 to $127.55, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| August 21, 2018 Filed Aug 22, 2018 23:16 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 60,000 | $131.35 | $7,881,000.00 |
DisclosureSEC source: 0001144204-18-045982 · tv501568_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,055,614 Read SEC document |
| August 09, 2018 Filed Aug 11, 2018 01:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 40,000 | $131.00 | $5,240,000.00 |
DisclosureSEC source: 0001144204-18-043690 · tv500789_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,115,614 Read SEC document |
| August 08, 2018 Filed Aug 11, 2018 01:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 50,000 | $131.05 | $6,552,500.00 |
DisclosureSEC source: 0001144204-18-043690 · tv500789_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,155,614 Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 01:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 100,000 | $131.00 | $13,100,000.00 |
DisclosureSEC source: 0001144204-18-042535 · tv500420_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,205,614 Read SEC document |
| August 03, 2018 Filed Aug 8, 2018 01:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 50,000 | $131.60 | $6,580,000.00 |
DisclosureSEC source: 0001144204-18-042535 · tv500420_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,305,614 Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 918 | $131.43 | $120,652.74 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 12 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,355,614 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F13 · price: Weighted average price. Price range in multiple transactions was $131.30 to $131.55, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,003 | $130.86 | $392,972.58 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 11 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,356,532 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · price: Weighted average price. Price range in multiple transactions was $130.30 to $131.20, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 5,215 | $129.94 | $677,637.10 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 10 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,359,535 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $129.30 to $130.25, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 5,002 | $128.78 | $644,157.56 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 9 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,364,750 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $128.30 to $129.25, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 500 | $127.68 | $63,840.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 8 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,369,752 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $127.30 to $128.25, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 108 | $132.25 | $14,283.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 7 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,370,252 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $132.25 to $132.30, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,500 | $131.09 | $196,635.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,370,360 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $130.80 to $131.75, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,700 | $130.32 | $351,864.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,371,860 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $129.80 to $130.75, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,200 | $129.21 | $155,052.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,374,560 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $128.80 to $129.75, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,743 | $128.05 | $607,341.15 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,375,760 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $127.70 to $128.65, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 15,111 | $127.24 | $1,922,723.64 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,380,503 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $126.70 to $127.65, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| July 31, 2018 Filed Aug 3, 2018 00:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 100,000 | $131.50 | $13,150,000.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,395,614 Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 23:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 300 | $115.97 | $34,791.00 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,495,614 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $115.90 to $116.00, inclusive. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 23:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 8,904 | $115.42 | $1,027,699.68 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,495,914 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $114.85 to $115.775, inclusive. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 23:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 13,246 | $115.35 | $1,527,926.10 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,504,818 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $115.30 to $115.60, inclusive. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 23:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 17,550 | $115.05 | $2,019,127.50 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,518,064 F1 · price: Weighted average price. Price range in multiple transactions was $114.30 to $115.25, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 01:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,285 | $117.50 | $503,487.50 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,535,614 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.60, inclusive. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,430 | $117.15 | $518,974.50 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,539,899 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $116.70 to $117.35, inclusive. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 998 | $115.86 | $115,628.28 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,544,329 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $115.50 to $116.25, inclusive. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 29,929 | $114.98 | $3,441,236.42 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,545,327 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $114.45 to 115.30, inclusive. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,643 | $113.99 | $529,255.57 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575,256 F1 · price: Weighted average price. Price range in multiple transactions was $113.45 to $114.40, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,710 | $117.54 | $200,993.40 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 19 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,579,899 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.58, inclusive. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 7,235 | $117.40 | $849,389.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 18 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,581,609 Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 50,000 | $117.25 | $5,862,500.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 17 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,588,844 Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,382 | $117.54 | $279,980.28 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 16 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638,844 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.625, inclusive. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 17,751 | $117.26 | $2,081,482.26 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 15 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,641,226 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $116.50 to $117.475, inclusive. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 25,000 | $117.00 | $2,925,000.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 14 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,658,977 Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 12,537 | $115.72 | $1,450,781.64 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 13 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,683,977 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $115.50 to $116.45, inclusive. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 50,000 | $115.00 | $5,750,000.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 12 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,696,514 Read SEC document |
| May 29, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 175,000 | $113.57 | $19,874,750.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 11 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,746,514 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $113.25 to $114.00, inclusive. Read SEC document |
| May 29, 2018 Filed Jun 1, 2018 01:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 95 | $115.50 | $10,972.50 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 10 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,514 Read SEC document |
| May 25, 2018 Filed May 26, 2018 00:28 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 100,000 | $115.00 | $11,500,000.00 |
DisclosureSEC source: 0001144204-18-031180 · tv495185_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,921,609 Read SEC document |
| May 23, 2018 Filed May 26, 2018 00:28 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,144 | $120.86 | $500,843.84 |
DisclosureSEC source: 0001144204-18-031180 · tv495185_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,021,609 F1 · price: Weighted average price. Price range in multiple transactions was $120.61 to $120.91, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:30 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 40,000 | $105.96 | $4,238,492.00 |
DisclosureSEC source: 0001179110-18-006165 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,162,153 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $105.05 to $106.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| April 03, 2018 Filed Apr 4, 2018 21:51 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 40,000 | $86.23 | $3,449,196.00 |
DisclosureSEC source: 0001179110-18-005425 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,214,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $85.60 to $87.00, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| April 02, 2018 Filed May 3, 2018 20:30 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 11,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006165 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,202,153 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 22:07 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 40,000 | $80.67 | $3,226,840.00 |
DisclosureSEC source: 0001179110-18-004395 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,254,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $80.50 to $81.25, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 12, 2018 Filed Mar 12, 2018 22:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 67,464 | $80.84 | $5,453,938.18 |
DisclosureSEC source: 0001179110-18-004089 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,294,053 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F4 · price: Weighted average price. Price range in multiple transactions was $80.50 to $81.15, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 22:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 78,129 | $81.19 | $6,343,168.50 |
DisclosureSEC source: 0001179110-18-004089 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,361,517 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F3 · price: Weighted average price. Price range in multiple transactions was $81.00 to $81.35, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 82,407 | $81.24 | $6,694,645.79 |
DisclosureSEC source: 0001179110-18-004089 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,439,646 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · price: Weighted average price. Price range in multiple transactions was $81.00 to $81.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.